Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2026-03-13 Legal Proceedings Report
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Attached details of an Appeal order received from Telangana GST Dept
Legal Proceedings Report Classification · 95% confidence The document is a letter addressed to stock exchanges providing an update on pending litigation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It includes details of an appeal order received from the Telangana GST Department and the status of the litigation. The document references regulatory compliance and provides an update on legal proceedings but does not contain financial statements or detailed financial analysis. The length is 3633 characters, which is relatively short and the document is primarily an update on litigation status. This fits the definition of a Legal Proceedings Report (LTR) rather than a full Annual Report, Interim Report, or Regulatory Filing. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2026-03-13 English
Name Change
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about the issuance of a fresh Certificate of Incorporation due to a change of the company's name from 'Akzo Nobel India Limited' to 'JSW Dulux Limited'. It references compliance with SEBI Listing Regulations and mentions filing necessary documents to update the name in exchange records. The document is short (2873 characters) and primarily serves as an official notification of a corporate name change, not a financial report or detailed filing. It does not contain financial data, audit information, or meeting materials. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-03-11 English
Intimation of change of name of the Company from Akzo Nobel India Limited to JSW Dulux Limited
Regulatory Filings Classification · 95% confidence The document is an exchange filing under SEBI Listing Regulations notifying the stock exchanges of a corporate name change and enclosing the fresh Certificate of Incorporation. It does not contain financial statements or detailed report data, nor is it a management change, share issue, or dividend notice. It is a general compliance/regulatory announcement, thus best classified under Regulatory Filings (RNS).
2026-03-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, informing them about the schedule of analyst and institutional investor meetings. It references compliance with the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about notifying the schedule of investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report contents included. The document is short (1975 characters) and serves as an announcement of a meeting schedule rather than a financial report or transcript. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-03-11 English
Intimation of Schedule of Analyst/Institutional Investor Meeting scheduled on 16 March 2026
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, informing them about the schedule of analyst and institutional investor meetings. It references compliance with the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about announcing the schedule of investor meetings, not the actual meeting transcript or financial results. The document length is short (1975 characters) and it is an announcement rather than a detailed report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings without substantive financial data or presentation content.
2026-03-11 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires disclosure of material information to stock exchanges. The content focuses on the pendency of litigation related to income tax assessment, providing details about the draft assessment order and its potential financial impact. It is addressed to the stock exchanges and signed by the company secretary and compliance officer. The document does not contain financial statements or detailed financial analysis but is a regulatory disclosure about ongoing legal proceedings. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about litigation impacting the company.
2026-03-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.